MedTrace Logo

Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients

NCT03071016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-03-04

No results posted yet for this study

Summary

This study is a non-interventional, multicentre, prospective, observational study to be conducted at 50 sites in India. The study targets to enrol 2000 patients with 40 patients per site. The study will be initiated after obtaining written approval of Independent Ethics Committee (IEC) /Institutional Review Board (IRB) and written informed consent of the patient.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dr Vijay Viswanathan, M.D., Ph.D., FRCP · MV Hospital Chennai India

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-04
Primary Completion
2018-03-03
Completion
2018-03-03

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071016 on ClinicalTrials.gov